Giovana R. Thomas

Also affiliated with University of Miami Health System, Sylvester Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Contributors”.

Contributors

Genomic and Personalized Medicine(2013)10.1016/b978-0-12-382227-7.00124-5

N/A

0DataRank · unranked

0 citations

Minhaz Uddin Ahmed, Sun Hee Ahn, R. Rand Allingham, Jude Alsarraj, Matthew L. Anderson +228 more

Contributors

Essentials of Genomic and Personalized Medicine(2010)10.1016/b978-0-12-374934-5.00076-3

N/A

0DataRank · unranked

0 citations

Peter J. Barnes, Ivor J. Benjamin, Mark Boguski, Brigitta Bondy, Roger E. Breitbart +64 more

Contributors

Genomic and Personalized Medicine(2009)10.1016/b978-0-12-369420-1.00122-0

N/A

0DataRank · unranked

0 citations

Matthew L. Anderson, Felicita Andreotti, Brian H. Annex, Anthony Antonellis, Dmitri Artemov +272 more

A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311

Oral Oncology(2020)10.1016/j.oraloncology.2020.104797

N/A

0DataRank · unranked

44 citations

Yael Flamand, F. Christopher Holsinger, Gregory S. Weinstein, Harry Quon, Ranee Mehra +28 more

Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6500

N/A

0DataRank · unranked

101 citations

Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra +15 more

Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6077

N/A

0DataRank · unranked

12 citations

Yael Flamand, Harry Quon, Joaquín J. García, Gregory S. Weinstein, Umamaheswar Duvvuri +12 more

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma

Cancer Research(2023)10.1158/0008-5472.can-23-0379

N/A

0DataRank · unranked

25 citations

Serena Zilio, Christie McGee, Boutheina Marnissi, Zoukaa Sargi, Elizabeth Franzmann +7 more

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6036

N/A

0DataRank · unranked

2 citations

Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, Joaquín J. García +11 more